Answers are grounded in this paper and cite their sources.
Review evaluates valerian’s efficacy on sleep and anxiety, highlighting safety and action mechanisms.
Sleep and anxiety disorders are among the most prevalent neuropsychiatric conditions worldwide, exerting a substantial burden on individual well-being, productivity, and public health systems. Although conventional pharmacotherapies such as benzodiazepines and non benzodiazepine hypnotics are effective in the short term, their long term use is frequently associated with adverse effects including tolerance, dependence, cognitive impairment, and withdrawal phenomena. These limitations have driven growing interest in plant based therapeutic alternatives with improved safety profiles. Valeriana officinalis L. (valerian) is one of the most extensively studied medicinal plants used traditionally and clinically for the treatment of insomnia, anxiety, and nervous restlessness. This review critically evaluates the botanical characteristics, phytochemical composition, mechanisms of action, pharmacological and clinical evidence, dosage forms, safety profile, and global usage of V. officinalis. Current evidence suggests that valerian exerts sedative and anxiolytic effects primarily through modulation of the γ aminobutyric acid (GABA) system, with additional contributions from adenosine and serotonin pathways. While clinical findings support its usefulness in mild to moderate sleep and anxiety disorders, variability in extract composition and study design highlights the need for further standardized, large scale clinical trials.
No takes yet. Share an insight, caveat, or question.
Amit Ram (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: